Effect of an Oral Neuromuscular Training Device on Dysphagia
NCT07451028 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2026-03-10
Summary
Dysphagia is a frequent complication following stroke, with an estimated prevalence of 42%. One training modality which have been implemented in both hospitals and municipalities for alleviating dysphagia are oral neuromuscular training devices. These devices are hand-held acrylic devices which are inserted between the lips and teeth by the patient or an assistant and pulled forward against lip pressure. According to the developers of one of these devices coined IQoro, the training strengthens the orofacial and pharyngeal muscles. One of recent studies by the developer of IQoro, have demonstrated a positive effect of IQoro in improving swallowing function and reducing clinical signs of aspiration among older people in intermediate care. However, aspiration risk was based on unblinded subjective water swallowing tests, and findings may therefore be biased. Additionally, it should be considered that the study was a cluster-randomized study, in which the intervention was performed in some care units, and the usual care was performed in other care units. Since usual care is not described in detail, results in favor of IQoro may also be due to differences in the usual care practice between care units. Focusing on individuals with stroke, only observational studies have been carried out. These studies have shown functional improvements in all four quadrants of the mouth, improved lip strength, and improved swallowing capacity. However, observational studies suffer from the inherent limitation that it is not possible to establish whether training with IQoro is actually the cause of these improvements.
The present research group recently published a small Randomized Controlled Trial (RCT), investigating the effectiveness of IQoro on swallowing function and decannulation in a very selective population of patients with cuffed tracheostomies due to severe acquired brain injury . Here, 22 subjects were randomized to either usual care, or usual care plus IQoro training as an add-on. In the study, there was no effect of IQoro in either time until decannulation, or swallowing function (as the implicit mechanism of action), compared with usual care. Patients with cuffed tracheostomy tubes are a very selective patient group, and results may not be generalized to a broader group of patients with post-stroke dysphagia.
Based on this, more high-quality clinical trials with IQoro, on a broader population of patients with dysphagia admitted for neurorehabilitation is warranted, in order to clarify whether training with IQoro have an effect on swallowing.
Aim and hypothesis The aim of this study is to investigate the effectiveness of oral neuromuscular training with IQoro on swallowing function in patients with dysphagia due to stroke. The hypothesis is that patients will have improved swallowing function because of training with IQoro as an add-on to usual care, compared with patients who only receive usual care.
Study design An assessor-blinded randomized controlled trial. Study participants will be randomly assigned to either the IQoro (intervention group) or usual care (control group). The trial will be conducted in accordance with the ethical principles outlined in the Declaration of Helsinki and approved by the Danish National Medical Research Ethics Committee
Conditions
Interventions
- DEVICE
-
IQoro
Training with IQoro according to instructions for use
- BEHAVIORAL
-
Usual Care
Usual care for dysphagia, diet modification, swallowing exercises, posture
Sponsors & Collaborators
-
University of Aarhus
lead OTHER
Principal Investigators
-
Jesper Fabricius, PhD · Hammel Neurorehabilitation Centre and University Research Clinic & Department of clinical medicine, Aarhus University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-03-27
- Primary Completion
- 2027-12-31
- Completion
- 2027-12-31
Countries
- Denmark
Study Locations
More Related Trials
-
Accurate Screening Tools for Dysphagia in Amyotrophic Lateral Sclerosis (ALS)
NCT02710162 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Evaluation of the Efficacy of a Two-week EMST on Dysphagia in Parkinsonian Patients
NCT05139342 ·Status: UNKNOWN ·Phase: NA
-
Treatment of Dysphagia Using the Mendelsohn Maneuver
NCT00592761 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Delineating Swallowing Impairment and Decline in ALS
NCT02962050 ·Status: COMPLETED
-
Screening in Oculopharyngeal Muscular Dystrophy
NCT02877784 ·Status: COMPLETED
-
Tongue Strength in Amyotrophic Lateral Sclerosis (ALS)
NCT02665663 ·Status: UNKNOWN ·Phase: NA
-
Treatment of Dysphagia in Oculopharyngeal Muscular Dystrophy by Autologous Transplantation of Myoblasts
NCT00773227 ·Status: COMPLETED ·Phase: PHASE2
-
Dysphagia, QoL and Attitudes Towards PEG in ALS Patients
NCT05336760 ·Status: RECRUITING
-
Evaluation of the Impact on Swallowing of Non Invasive Ventilation
NCT01519388 ·Status: COMPLETED ·Phase: NA
-
Fatigue in Patients With Amyotrophic Lateral Sclerosis
NCT04468191 ·Status: WITHDRAWN ·Phase: NA
-
Ataxia-telangiectasia: Treating Mitochondrial Dysfunction With a Novel Form of Anaplerosis
NCT04513002 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Functional Exercise in Patients With Spinal Bulbar Muscular Atrophy
NCT01369901 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Phagenyx® Registry Study
NCT06866418 ·Status: RECRUITING
-
Phase 1 Dose Escalation and PK Study of Cu(II)ATSM in ALS/MND
NCT02870634 ·Status: COMPLETED ·Phase: PHASE1
-
Cortico-Spinal tDCS as Rehabilitative Intervention in Amyotrophic Lateral Sclerosis
NCT04293484 ·Status: COMPLETED ·Phase: NA
-
A Study of the Effect of BIIB023 on Muscle Atrophy in Healthy Male Volunteers
NCT01943513 ·Status: COMPLETED ·Phase: PHASE1
-
Innovative Measures of Speech and Swallowing Dysfunction in Neurological Disorders
NCT02118805 ·Status: COMPLETED
-
Lung Insufflation Capacity Training and Respiratory Function in Amyotrophic Lateral Sclerosis
NCT07257302 ·Status: RECRUITING ·Phase: NA
-
Steroid-Antiviral Treatment in Rehabilitation of Facial Palsy
NCT02328079 ·Status: COMPLETED ·Phase: NA
-
Muscle Training of Patients With Amyotrophic Lateral Sclerosis (ALS)
NCT01504009 ·Status: COMPLETED ·Phase: NA
-
The Effect of Oral and Nasal Feeding on Cerebral Small Vessel Disease
NCT06248892 ·Status: RECRUITING ·Phase: NA
-
Dose-Escalation, Safety and Pharmacokinetic Study of IC14 in Motor Neurone Disease
NCT03487263 ·Status: COMPLETED ·Phase: PHASE1
-
Implementation of FEES in Spinal Muscle Atrophy
NCT04773470 ·Status: COMPLETED ·Phase: NA
-
Use of Dynamic Arm Supports to Promote Activities of Daily Living in Individuals With DMD
NCT03531788 ·Status: TERMINATED ·Phase: NA
-
Phase II Study of Leuprolide and Testosterone for Men With Kennedy's Disease or Other Motor Neuron Disease
NCT00004771 ·Status: COMPLETED ·Phase: PHASE2